<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04153383</url>
  </required_header>
  <id_info>
    <org_study_id>KUH0000000123</org_study_id>
    <nct_id>NCT04153383</nct_id>
  </id_info>
  <brief_title>Milrinone on Left Ventricular Diastolic Performance During Off-pump Coronary Artery Bypass Surgery</brief_title>
  <official_title>Milrinone on Left Ventricular Global Performance During Diastole in Patients Undergoing Off-pump Coronary Artery Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the changes in global strain of the left ventricle
      before and after milrinone administration in order to find out whether milrinone improves LV
      diastolic performance in patients undergoing coronary artery bypass surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>peak velocity of mitral annular tissue Doppler during early relaxation</measure>
    <time_frame>15 mini after milrinone administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>peak velocity of mitral annular tissue Doppler during atrial contraction</measure>
    <time_frame>15 mini after milrinone administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>peak velocity of mitral annular tissue Doppler during systole</measure>
    <time_frame>15 min after milline administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global longitudinal strain of the left ventricle</measure>
    <time_frame>15 mini after milrinone administration</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>TMAD</arm_group_label>
    <description>Tissue motion annular displacement (TMAD) transesophageal echocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Milrinone Injection</intervention_name>
    <description>giving IV milrinone: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/min IV</description>
    <arm_group_label>TMAD</arm_group_label>
    <other_name>Milrinone</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        valvular heart disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient agree and provide written informed consent.

          -  patient undergoing elective coronary artery bypass graft surgery

          -  preoperative LV EF&gt;50% (TTE)

        Exclusion Criteria:

          -  preoperative cardiac dysrhythmia

          -  preoperative IABP

          -  use of other inotropic agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 4, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Milrinone</keyword>
  <keyword>diastolic function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Milrinone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

